Bemitil for prevention of occupational hearing loss — patent RU2017483C1
Patent disclosure · 1994
- What the patent describes
- 148 workers aged 22–24 exposed to intense aircraft-engine noise: placebo n=25, conventional prophylaxis n=39, Bemitil n=84.
- Reported evidence
- The patent reports hearing loss at one year in 8/25 placebo recipients, 7/39 receiving a standard multi-agent regimen, and 5/84 receiving Bemitil. Filed 9 November 1989; published 15 August 1994.
Reported patent results
Reported findings
The patent reports less hearing loss after one year in the Bemitil group.
148 workers aged 22–24 exposed to intense aircraft-engine noise: placebo n=25, conventional prophylaxis n=39, Bemitil n=84.
Population or model 148 workers aged 22–24 exposed to intense aircraft-engine noise: placebo n=25, conventional prophylaxis n=39, Bemitil n=84.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Hearing loss at one year | 5/84 with Bemitil, 7/39 with conventional prophylaxis, 8/25 with placebo | Hearing loss of varying degree; allocation and masking unverified · 1 year |
| Illustrative worker: recovery time | 4.5 hours without Bemitil versus 2 hours after a treatment cycle | Single-worker before/after example, not a cohort mean |
| Illustrative worker: high-frequency threshold shift | 45–55 dB without versus 30 dB after a Bemitil cycle | An individual example; exposure comparability not established |
Unequal, apparently nonrandom groups and incomplete baseline/exposure data prevent a causal prevention estimate. Hearing protection remains a separate requirement.
Source for these results ↗ · Reviewed 2026-11-06
Patent claims and provenance
Use. Historical Bemitil-related hearing-protection use disclosure; patent reports are not independent randomized clinical evidence.
A patent disclosure is not clinical proof, marketing approval or a legal opinion. Related publications and patent family members may describe the same experiments.
- Publication
- RU2017483C1 ↗ · 1994-08-15
- Earliest priority / filing
- 1989-11-09 / 1989-11-09
- Original applicant / assignee
- Глазников Лев Александрович
- Indexed status
- Not shown; official status unverified · checked 2026-11-06
- Patent family
- 21478461 · family publications are related filings, not independent studies.
Original title, inventors and related publications
Agent for prophylaxis of professional hypoacusis
Inventors: Ю.К. Ревской; Л.А. Глазников; Б.Л. Макеев; В.Р. Гофман; М.А. Нестеров.
Study limitations and source details
Study limitations
- Random allocation, blinding, exposure comparability and attrition are not established by the patent.
- Patent claims are not equivalent to a peer-reviewed clinical trial or confirmed prevention.
- This does not replace hearing protection or occupational exposure controls.
Source details
Patent text and dates checked. The numerical comparison is attributed to the patent, not independently verified patient data.
Selected reported results and source limitations reviewed; not a complete risk-of-bias or experimental audit.
Sources checked
Citation
L. A. Glaznikov, Iu. K. Revskoi, B. L. Makeev, V. R. Gofman, M. A. Nesterov. Bemitil for prevention of occupational hearing loss — patent RU2017483C1 Russian patent RU2017483C1; priority 1989